Skip to content

APOTHEEK KEYMOLEN: what changed

BE 0456.560.291NACE 47.730, Retail sale of pharmaceutical productsOther company

Position among the sector peers

What moved between 2024 and 2025

Net result for the year
€128,654
2024 · €142,860-€14,206
Equity
€440,440
2024 · €609,586-€169,147
Cash
€152,093
2024 · €137,074+€15,019
Balance sheet total
€920,917
2024 · €932,708-€11,790

Largest movements

2024 to 2025
Assets
  • Current investments -€53,994

    down €53,994 (-10.6%), from €508,453 to €454,459

  • Receivables within one year +€19,744

    up €19,744 (+25.7%), from €76,721 to €96,465

  • Cash +€15,019

    up €15,019 (+11.0%), from €137,074 to €152,093

    mainly Other debts (+€150,782) and Net result for the year (+€128,654)

Equity and liabilities
  • Reserves -€169,147

    down €169,147 (-28.6%), from €590,994 to €421,848

  • Other debts +€150,782

    up €150,782 (+70.4%), from €214,082 to €364,864

Income statement
  • Staff costs +€16,961

    up €16,961 (+24.4%), from €69,653 to €86,614

  • Financial income -€3,800

    down €3,800 (-34.0%), from €11,180 to €7,379

Change in the result, 2024 to 2025

effect on the result

For each income-statement line you see the change as its effect on the result.

Result 2024 €142,860
Gross operating margin +€2,040
Staff costs -€16,961
Depreciation +€2,694
Other operating charges -€106
Financial income -€3,800
Financial charges +€2,242
Taxes -€315
Result 2025 €128,654
raises the resultlowers the result

Derived cash bridge

cash 2024 to 2025

The bridge is derived from the 2024 and 2025 balance sheets and the 2025 result. There is no filed cash-flow statement. You see where the money came from and where it went.

From operations +€275,421
Investment +€37,398
Financing -€297,800
Cash 2024 €137,074
Net result for the year +€128,654
Depreciation +€9,074
Stocks and contracts -€2,863
Receivables within one year -€19,744
Deferred charges and accrued income +€2,944
Trade debts +€6,772
Tax, wage and social debts +€2,025
Other debts +€150,782
Accrued charges and deferred income -€2,222
Investment in fixed assets (net) -€16,596
Current investments +€53,994
Contributions, distributions and other -€297,800
Cash 2025 €152,093
brings cash intakes cash out
Every line side by side 42 lines
Line Code 2024 2025 Change %
Total assets 20/58 €932,708 €920,917 -€11,790 -1.3%
Fixed assets 21/28 €57,372 €64,894 +€7,522 +13.1%
Tangible fixed assets 22/27 €57,372 €64,894 +€7,522 +13.1%
Land and buildings 22 €43,944 €40,291 -€3,653 -8.3%
Plant, machinery and equipment 23 €10,861 €23,502 +€12,641 +116%
Furniture and vehicles 24 €2,568 €1,101 -€1,467 -57.1%
Current assets 29/58 €875,335 €856,023 -€19,312 -2.2%
Stocks and contracts in progress 3 €136,519 €139,382 +€2,863 +2.1%
Stocks 30/36 €136,519 €139,382 +€2,863 +2.1%
Amounts receivable within one year 40/41 €76,721 €96,465 +€19,744 +25.7%
Trade receivables 40 €76,721 €96,465 +€19,744 +25.7%
Current investments 50/53 €508,453 €454,459 -€53,994 -10.6%
Cash at bank and in hand 54/58 €137,074 €152,093 +€15,019 +11.0%
Deferred charges and accrued income 490/1 €16,568 €13,624 -€2,944 -17.8%
Total equity and liabilities 10/49 €932,708 €920,917 -€11,790 -1.3%
Equity 10/15 €609,586 €440,440 -€169,147 -27.7%
Contributions 10/11 €18,592 €18,592 = 0.0%
Reserves 13 €590,994 €421,848 -€169,147 -28.6%
Distributable reserves 133 €590,994 €421,848 -€169,147 -28.6%
Profit (loss) carried forward 14 €0 €0 =
Amounts payable 17/49 €323,121 €480,478 +€157,356 +48.7%
Amounts payable within one year 42/48 €310,267 €469,846 +€159,579 +51.4%
Trade debts 44 €61,455 €68,227 +€6,772 +11.0%
Suppliers 440/4 €61,455 €68,227 +€6,772 +11.0%
Taxes, remuneration and social security 45 €34,730 €36,755 +€2,025 +5.8%
Taxes 450/3 €21,509 €17,513 -€3,996 -18.6%
Remuneration and social security 454/9 €13,221 €19,242 +€6,021 +45.5%
Other amounts payable 47/48 €214,082 €364,864 +€150,782 +70.4%
Accrued charges and deferred income 492/3 €12,854 €10,632 -€2,222 -17.3%
Remuneration, social security and pensions 62 €69,653 €86,614 +€16,961 +24.4%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €11,768 €9,074 -€2,694 -22.9%
Other operating charges 640/8 €267 €373 +€106 +39.5%
Gross operating margin 9900 €280,973 €283,013 +€2,040 +0.7%
Operating profit (loss) 9901 €199,285 €186,952 -€12,333 -6.2%
Financial income 75/76B €11,180 €7,379 -€3,800 -34.0%
Recurring financial income 75 €11,180 €7,379 -€3,800 -34.0%
Financial charges 65/66B €14,368 €12,126 -€2,242 -15.6%
Recurring financial charges 65 €14,368 €12,126 -€2,242 -15.6%
Profit (loss) for the period before taxes 9903 €196,097 €182,205 -€13,892 -7.1%
Income taxes 67/77 €53,237 €53,552 +€315 +0.6%
Profit (loss) for the period 9904 €142,860 €128,654 -€14,206 -9.9%
Profit (loss) for the period to be appropriated 9905 €142,860 €128,654 -€14,206 -9.9%

Value

latest balance sheet 31-12-2025 · indication, not a valuation or advice

Value of the equity

Indication, not a valuation or advice
€688,255 to €875,470

Midpoint €766,261 · 50% capitalised earnings, 50% adjusted equity

Capitalisation rate 12% result over 3 years earnings weight 50%

Worked out with Checked's starting values, not your estimate. Change the assumptions and the value follows.

Adjusted equity €440,440
Capitalised earnings €936,071 to €1.3m
Indication €688,255 to €875,470

Adjusted equity

balance sheet 31-12-2025
Equity (10/15)
€440,440
Revaluation of assets
€0
Deferred tax on the revaluation
€0
Other adjustment
€0
Adjusted equity
€440,440

Capitalised earnings

net result for the year (9904)
2025
€128,654
2024
€142,860
2023
€121,638
2022
€105,764
2021
€97,064
Average result
€131,050
Divided by the capitalisation rate
14% / 12% / 10%
Capitalised earnings
€936,071 / €1.1m / €1.3m

Limits of the indication

  • Checked holds no market prices or comparable transactions.
  • Anything after the latest accounts and items off the balance sheet (guarantees, leases, disputes) are left out.
  • Checked does not know the real value of buildings, stock and receivables. Enter your own revaluation or adjustment for it.
  • The result is not corrected for the manager's pay. If the company pays less or more than a market salary, the capitalised earnings are too high or too low.
  • The owner's role in the business, synergies for a buyer and the tax consequences of a sale are left out.

For a valuation to base a decision on, go to a company auditor or a certified accountant.

Calculation and sources

Source: filed annual accounts (NBB) and main activity (KBO). The movements compare the financial years ended 31 December 2024 and 31 December 2025. Green is a favourable move for that line, red an unfavourable one. The value is an indication, not a valuation or advice. Prepared on 20 November 2026 via checked.be.